Patent for BioProspect

By Staff Writers
Monday, 20 October, 2008

Brisbane company BioProspect (ASX: BPO) has been granted a patent on its Termilone product for termite control.

Termoline is based on ermophilone oil, extracted from the native Australian tree False Sandalwood.

The oil acts as both a toxic agent on termites and a repellant, but has shown low toxicity in mammalian species.

The company is also developing a range of Bioeffectives for the animal health and nutrition markets.

Related News

Noxopharm says paper reveals science behind its immune system platform

Clinical-stage Australian biotech company Noxopharm Limited says a Nature Immunology...

Neurosensing/neurostimulation implants session to be held on Monday

On Monday, a session at UNSW Sydney will include people who are benefiting from bioelectronics...

argenx and Monash University partner against autoimmune diseases

To advance a pioneering molecule for autoimmune diseases, global immunology company argenx has...


  • All content Copyright © 2026 Westwick-Farrow Pty Ltd